Cargando…

The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer

BACKGROUND: The management of NSCLC has been transformed by stratified medicine. The National Lung Matrix Trial (NLMT) is a UK-wide study exploring the activity of rationally selected biomarker/targeted therapy combinations. PATIENTS AND METHODS: The Cancer Research UK (CRUK) Stratified Medicine Pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Middleton, G., Crack, L. R., Popat, S., Swanton, C., Hollingsworth, S. J., Buller, R., Walker, I., Carr, T. H., Wherton, D., Billingham, L. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658545/ https://www.ncbi.nlm.nih.gov/pubmed/26410619 http://dx.doi.org/10.1093/annonc/mdv394

Ejemplares similares

Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations
por: Hubner, Richard A., et al.
Publicado: (2011)

Matrix metalloproteinases in lung biology
por: Parks, William C, et al.
Publicado: (2001)

Problems of variable biomarker evaluation in stratified medicine research—A case study of ERCC1 in non-small-cell lung cancer
por: Malottki, Kinga, et al.
Publicado: (2016)

Risk Stratification in Lung Resection
por: Salati, Michele, et al.
Publicado: (2016)

Use of precision cut lung slices as a translational model for the study of lung biology
por: Liu, Guanghui, et al.
Publicado: (2019)

Risk Stratification for Lung Cancer Patients
por: Jain, Anchal, et al.
Publicado: (2022)

Quantitative Stratification of Diffuse Parenchymal Lung Diseases
por: Raghunath, Sushravya, et al.
Publicado: (2014)

Buccal Spectral Markers for Lung Cancer Risk Stratification
por: Radosevich, Andrew J., et al.
Publicado: (2014)

Evidence of Lung Function for Stratification of Cardiovascular Disease Risk
por: Lee, Hwa Mu, et al.
Publicado: (2011)

Do we need to see to believe?—radiomics for lung nodule classification and lung cancer risk stratification
por: Khawaja, Ali, et al.
Publicado: (2020)

Durable response of multiple myeloma and non‐small cell lung cancer with simultaneous, biologically targeted treatment
por: Kaiser, Martin F., et al.
Publicado: (2020)

Highlights in lung cancer in 2019
por: Lim, Kok Haw Jonathan, et al.
Publicado: (2020)

Personalising lung cancer screening: An overview of risk‐stratification opportunities and challenges
por: ten Haaf, Kevin, et al.
Publicado: (2021)

Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit
por: Khakwani, A, et al.
Publicado: (2013)

Lung Ultrasound B-Lines in Interstitial Lung Disease: Moving From Diagnosis to Prognostic Stratification
por: Volpicelli, Giovanni
Publicado: (2020)

Consensus clustering methodology to improve molecular stratification of non-small cell lung cancer
por: Manganaro, L., et al.
Publicado: (2023)

The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer
por: Patel, Akshay J., et al.
Publicado: (2020)

PPARs: Regulators and Translational Targets in the Lung
por: Reddy, Raju C., et al.
Publicado: (2012)

Human-scale lung regeneration based on decellularized matrix scaffolds as a biologic platform
por: Ohata, Keiji, et al.
Publicado: (2020)

A combined tissue‐engineered/in silico signature tool patient stratification in lung cancer
por: Göttlich, Claudia, et al.
Publicado: (2018)

Coupled immune stratification and identification of therapeutic candidates in patients with lung adenocarcinoma
por: Hu, Weilei, et al.
Publicado: (2020)

Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease
por: Avouac, Jérôme, et al.
Publicado: (2020)

Risk stratification in differentiated thyroid cancer with RAI-avid lung metastases
por: Ohkuwa, Keiko, et al.
Publicado: (2021)

Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry
por: Banydeen, Rishika, et al.
Publicado: (2023)

Role of the extracellular matrix in variations of invasive pathways in lung cancers
por: de Sá, V.K., et al.
Publicado: (2013)

Analysis of intratumor heterogeneity unravels lung cancer evolution
por: de Bruin, Elza C, et al.
Publicado: (2015)

Lung extracellular matrix and redox regulation
por: Watson, Walter H., et al.
Publicado: (2016)

Lung extracellular matrix modulates KRT5(+) basal cell activity in pulmonary fibrosis
por: Hewitt, Richard J., et al.
Publicado: (2023)

Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas
por: Menor, Mark, et al.
Publicado: (2019)

PPARs in Lung Biology and Disease
por: Standiford, Theodore J., et al.
Publicado: (2007)

Small-Cell Lung Cancer in England: Trends in Survival and Chemotherapy Using the National Lung Cancer Audit
por: Khakwani, Aamir, et al.
Publicado: (2014)

Unlocking Pandora's box: personalising cancer cell death in non-small cell lung cancer
por: Fennell, Dean A, et al.
Publicado: (2012)

Treatment options for small cell lung cancer – do we have more choice?
por: Puglisi, M, et al.
Publicado: (2010)

Quantitative proteomic profiling of extracellular matrix and site-specific collagen post-translational modifications in an in vitro model of lung fibrosis
por: Merl-Pham, Juliane, et al.
Publicado: (2019)

Expanding Video Consultation Services at Pace and Scale in Scotland During the COVID-19 Pandemic: National Mixed Methods Case Study
por: Wherton, Joseph, et al.
Publicado: (2021)

Management of febrile neutropenia in the United Kingdom: time for a national trial?
por: Innes, H, et al.
Publicado: (2005)

Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?
por: Thomas, Hannah M. T., et al.
Publicado: (2022)

What transposable elements are differentially translated in lung cancer?
por: Yang, Wan R, et al.
Publicado: (2013)

Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma
por: Ghorani, E, et al.
Publicado: (2018)

Matrix Metalloproteinase Activity in Pediatric Acute Lung Injury
por: Kong, Michele YF, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_u1qsj8v6pdfr8dacp4hc533g82